Evaluate for Consulting Firms
Turn complex pharma and biotech questions into defensible client strategies
Evaluate gives consulting teams the trusted market intelligence they need to answer difficult client questions, develop evidence-backed strategies, and deliver recommendations that stand up to scrutiny.
Why consulting teams use Evaluate
Help your clients make their next move with confidence
Clients turn to consulting firms for clarity when the evidence is complex, the stakes are high, and the right answer is not immediately obvious.
Whether they are evaluating an asset, entering a new market, reshaping a portfolio or looking for their next growth opportunity, they expect recommendations that are timely, rigorous, and grounded in a complete view of the market.
Evaluate brings together commercial, clinical, competitive and deal intelligence across pharma and biotech. Your teams spend less time finding and validating information and more time developing the insights clients value.
companies covered
pharma and biotech products tracked
consensus forecasts
products back to 2003
Trusted intelligence across the pharma and biotech ecosystem
Built for consulting teams delivering high-stakes pharma and biotech advice.
- Forecasts to 2032 for forward-looking market sizing, diligence and strategic recommendations
- Historic sales data back to 1996 for long-term performance context
- Coverage across private and listed biopharma companies, marketed products and pipeline assets
Built for key consulting workflows
Get in touch
Whether you are responding to an RFP, assessing an asset, building a market forecast or preparing a board-level recommendation, Evaluate helps you bring stronger evidence into every stage of the engagement.
RFP & New Business Support
Strengthen RFP responses and pitches with trusted pharma and biotech evidence, helping your teams move faster and make a more compelling case.
Use Evaluate to quickly understand the prospective client’s portfolio, market position, competitive environment, and upcoming priorities. Bring relevant evidence into your proposed approach and demonstrate that your team understands the questions behind the brief.
Useful when you need to:
Respond to RFPs and pitches within demanding timelines
Demonstrate a strong understanding of the client’s markets and portfolio
Support your proposed approach with trusted market evidence
Asset & Company Diligence
Assess assets, companies and market opportunities with trusted data and forecasts that support rigorous diligence and defensible board-level recommendations.
Bring together product performance, pipeline progress, forecast potential, competitive positioning, deal activity, and upcoming catalysts to develop a clear view of commercial opportunity and risk.
Useful when you need to:
Assess the commercial potential of an asset or company
Gauge pipeline strength, competitive positioning and market risk
Support defensible board or investment committee recommendations
Competitive Intelligence
Track competitor activity, pipeline developments, regulatory shifts, and market dynamics so your teams can advise clients with greater speed, clarity and confidence.
Compare marketed and pipeline products across indications, mechanisms of action, targets, development stages, companies, and forecast potential. Monitor the developments that could reshape a market or challenge an existing strategy.
Useful when you need to:
Build competitive landscape assessments
Identify emerging competitors, threats and areas of opportunity
Track developments that could impact client strategy
Forecasting & Valuation
Develop forecasts and valuations grounded in trusted market data, consensus expectations and scenario analysis, giving clients evidence they can scrutinize and defend.
Use historical sales, consensus forecasts, epidemiology, pipeline data, and indication-level intelligence to build or challenge commercial assumptions and evaluate potential outcomes.
Useful when you need to:
Size markets and develop product forecasts
Build and pressure test commercial scenarios
Support asset or company valuations with trusted benchmarks
Client Pitch and Proposal Development
Show prospective and existing clients that you understand the market forces affecting their business.
Use company, portfolio, pipeline and market intelligence to develop relevant points of view, tailor proposals and demonstrate expertise before an engagement begins.
Unlike formal RFP support, this workflow helps teams create proactive pitches, prepare for client meetings and identify ways to expand existing relationships.
Useful when you need to:
Prepare for client meetings and account reviews
Personalize pitches and proposals with relevant market evidence
Identify issues that could lead to future projects
Pharma and Biotech Account Targeting
Identify the companies and market developments most likely to create demand for consulting support.
Track pipeline changes, product performance, deal activity, portfolio developments, and upcoming milestones to prioritize accounts and uncover relevant reasons to engage.
Useful when you need to:
Prioritize the companies most likely to need consulting support
Identify timely market developments and conversation starters
Personalize outreach and uncover account expansion opportunities
One connected view of the pharma and biotech market
Evaluate gives consulting teams access to the data, intelligence and analysis behind the strategic questions their clients are asking.
Consensus forecasts and sales data
Size markets, assess future potential and benchmark performance across products, indications, companies and therapy areas.
Company and asset coverage
Understand company strategies, marketed products, development pipelines, portfolio priorities, and future growth drivers.
Pipeline intelligence
Track development activity, clinical progress, and future competitive threats across the pharma and biotech market.
Epidemiology data
Assess patient populations, disease trends and indication-level market opportunities.
Deal intelligence
Review licensing, acquisition, partnership, and financing activity to understand market appetite and benchmark comparable transactions.
Clinical and regulatory events
Track upcoming milestones and market-moving events that could affect products, companies and client strategies.
News and expert analysis
Stay informed about the commercial, regulatory and strategic developments shaping pharma and biotech.
Reporting and data exports
Export data for further modeling, presentations, workshops and client deliverables.
Bring more evidence to every client recommendation
Learn how Evaluate can help your team deliver stronger recommendations, differentiate your firm and identify new opportunities for growth.
Choose a time to talk
Book directly with one of our specialists. No forms. No waiting. A focused conversation with someone who knows the data.
Typically 30 minutes, with a specialist matched to your sector
No obligation. Cancel or reschedule any time
Share a few details and we'll be in touch
We’ll help you understand how Evaluate could support your team, your client work and your priorities.
Frequently Asked Questions
How does Evaluate support consulting engagements?
Evaluate provides market forecasts, historical sales, company intelligence, pipeline information, deal activity, event tracking and expert analysis that consulting teams can use throughout strategy, diligence and commercial engagements.
Can Evaluate help consulting teams work more efficiently?
Yes. Evaluate brings together intelligence from across the pharma and biotech market, reducing the time teams spend finding, validating and combining information from fragmented sources.
Can Evaluate support asset and company diligence?
Yes. Teams can use Evaluate to assess product performance, forecast potential, pipeline quality, competitive positioning, relevant deals and upcoming catalysts when evaluating assets and companies.
Can Evaluate help with pharma market sizing and forecasting?
Yes. Consulting teams can use historical sales, consensus forecasts, epidemiology and indication-level intelligence to assess current market value, future growth potential and different commercial scenarios.
How does Evaluate support competitive landscape analysis?
Evaluate helps teams compare marketed and pipeline products by company, indication, target, mechanism of action, development stage and forecast potential.
Can Evaluate support valuation work?
Yes. Evaluate provides forecast data, market benchmarks and scenario analysis that teams can use to build, validate or pressure-test valuation assumptions.
Can Evaluate help consulting firms win new clients?
Yes. Teams can use Evaluate to understand target companies, identify relevant market developments and bring stronger evidence into RFP responses, pitches, proposals and client conversations.
